$55.00
High-purity CJC-1295 (No DAC) and Ipamorelin blend (5/5mg) for laboratory research. This synergistic combination of a GHRH analog and a selective GHSR-1a agonist is designed for studying endogenous growth hormone pulsatile release. Buy CJC-1295 Ipamorelin blend online with guaranteed quality for your experimental protocols.
CJC‑1295 (no DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog engineered to enhance the amplitude and frequency of endogenous growth hormone (GH) secretion. Unlike the DAC‑modified version, the NO‑DAC form lacks the Drug Affinity Complex, giving it a shorter half‑life and a more physiologically pulsatile GH‑release profile, closely mimicking native GHRH signaling.
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue receptor (GHSR‑1a) agonist, belonging to the class of ghrelin mimetics. It stimulates endogenous growth hormone (GH) release through targeted activation of the ghrelin receptor without significantly affecting cortisol, prolactin, or ACTH, giving it one of the cleanest endocrine profiles among GHRP‑class peptides.
CJC‑1295 (no DAC) is a synthetic growth hormone–releasing hormone (GHRH) analog engineered to enhance the amplitude and frequency of endogenous growth hormone (GH) secretion. Unlike the DAC‑modified version, the NO‑DAC form lacks the Drug Affinity Complex, giving it a shorter half‑life and a more physiologically pulsatile GH‑release profile, closely mimicking native GHRH signaling.
Ipamorelin is a synthetic pentapeptide and highly selective growth hormone secretagogue receptor (GHSR‑1a) agonist, belonging to the class of ghrelin mimetics. It stimulates endogenous growth hormone (GH) release through targeted activation of the ghrelin receptor without significantly affecting cortisol, prolactin, or ACTH, giving it one of the cleanest endocrine profiles among GHRP‑class peptides.
